Under Armour Is the S&P 500’s Worst Performer in May. These Are the Other Stocks.

[view original post]

A customer tries on an Under Armour shoe in Houston. The retailer has performed the worst among all S&P 500 stocks in May.

Brandon Bell/Getty Images

Coming into Tuesday, the S&P 500  posted a gain of about 0.6% for May. A rally last week pulled the index into the green in what has been a volatile month.

These stocks have been the worst performers in the S&P 500 during May.

1: Under Armour

Under Armour  (ticker: UAA) delivered quarterly earnings earlier this month that missed Wall Street expectations. The company cited supply-chain challenges and pandemic uncertainty. But what really disappointed investors was the fiscal-year outlook, which came in below what analysts had been expecting.

Under Armour guided for adjusted earnings the fiscal year ending next March of 63 cents to 68 cents a share, below analysts’ forecasts of 78 cents. Coming into Tuesday, the stock has fallen 33.3% this month, according to Dow Jones Market Data. It has lost half its value this year.

2: Target

Retailer Target (TGT) had its worst day since 1987 in May. The stock dropped sharply on a quarterly earnings report that was well below analysts’ forecasts and that highlighted unexpectedly high costs. With historically high inflation, shoppers have been pulling back.

Target has declined 28.5% in May.

3: Expedia

Expedia (EXPE) stock fell at the start of the month even though travel demand has come back and the company’s loss narrowed in its first quarter. Revenue in the period also climbed by 80% from last year and matched analysts’ forecasts of $2.25 billion.

It appears the stock’s strong recovery already was priced in the stock. Shares have dropped down 26% in May and 30% this year.

4: Royal Caribbean

Royal Caribbean (ticker: RCL) stock has fallen this month even though the cruise line operator said it continues to move toward profitability. The company said operating cash flow was “slightly negative in March” but was “turning positive in April.”

The stock has dropped more than 25% this month.

5: DexCom

Coming into Tuesday, shares of medical device manufacturing company DexCom (DXCM) have fallen 24% in May. A report from Bloomberg last week said Dexcom was in talks to acquire automated insulin technology developer Insulet (PODD).

Dexcom was rising 5.3% Tuesday after saying in a press release that it wasn’t in active discussions regarding a merger transaction at this time.”

Write to Karishma Vanjani at karishma.vanjani@dowjones.com